MITBX
Price
$35.93
Change
+$0.12 (+0.34%)
Updated
Aug 21 closing price
Net Assets
6.97B
VSTSX
Price
$362.62
Change
+$1.77 (+0.49%)
Updated
Aug 21 closing price
Net Assets
2.29T
Interact to see
Advertisement

MITBX vs VSTSX

MITBX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
MITBX vs. VSTSX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MITBX is a StrongBuy and VSTSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.29T vs. MITBX (6.97B). VSTSX pays higher dividends than MITBX: VSTSX (1.08) vs MITBX (0.00). MITBX was incepted earlier than VSTSX: MITBX (33 years) vs VSTSX (10 years). MITBX (1.44) is less costly to investors than VSTSX (0.01). MITBX is a more actively managed with annual turnover of: 26.00 vs. VSTSX (3.00). MITBX has a lower initial minimum investment than VSTSX: MITBX (1000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.04 vs. MITBX (1.53). VSTSX return over 5 years is better than : 66.67 vs. MITBX (-12.79).
MITBXVSTSXMITBX / VSTSX
Total Expense Ratio1.440.0114,400%
Annual Report Gross Expense Ratio1.440.0114,400%
Fund Existence33 years10 years-
Gain YTD9.04412.87670%
Front LoadN/AN/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.97B2.29T0%
Annual Yield % from dividends0.001.08-
Returns for 1 year1.5321.047%
Returns for 3 years8.6474.3712%
Returns for 5 years-12.7966.67-19%
Returns for 10 years28.18238.9412%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCEX105.501.05
+1.01%
Rydex Europe 1.25x Strategy C
LVAVX17.340.12
+0.70%
LSV Conservative Value Equity Investor
NWAEX20.360.08
+0.39%
Nationwide BNY Mellon Dyn US Core Eagle
WWIAX13.510.03
+0.22%
Westwood Income Opportunity A
JFNSX87.14N/A
N/A
Janus Henderson Global Life Sciences S